Pedopsychiatric and Multidisciplinary Research Devoted to Children Exposed to the Attack in Nice on July 14, 2016
NCT ID: NCT03356028
Last Updated: 2023-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
728 participants
INTERVENTIONAL
2017-11-21
2044-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After a traumatic event, multiple clinical consequences may appear in children. Among these consequences, the most common is Post-Traumatic Stress Disorder (PTSD). The aim of the study is to characterize the psycho-social factors of risk and / or protection interfering in the children's future, following the mass trauma of 14 July 2016 in Nice on a sample of pediatric population exposed in comparison of children controls.
Ancillary study, entilted "The Physalis Child", prospectively observe the presence or not of non-psychotic acousto-verbal hallucinations (AVH) in the population with PTSD from the "Program 14-7". The main objective of this ancillary study will be to identify factors of social and emotional cognition linked to the presence of non-psychotic HAV within the cohort of children exposed to the mass trauma of July 14, 2016 in Nice but also to any type of individual trauma.
Ancillary study, entilted "trail of the 14 July attack", prospectively observe the risk of traumatic reactivation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improvement of the Diagnosis and Medico-legal Management of Psychological Trauma in Patients Involved in the Terrorist Attack in Nice on the 14th July 2016
NCT03264469
Hospital Cohort Survey of Public Health Post-attack of July 14, 2016
NCT03353805
Mid-Term Follow-up Assessment After Exposure to Natural Disaster
NCT05473962
EMDR Therapy in Young Children, a Double-blinded Randomized Controlled Trial
NCT05419934
Online PTSD Treatment for Young People and Carers - Case Series
NCT03935035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Nice, 86 deaths, including 10 children, the youngest at 4, were recorded. A number of children, still difficult to assess exactly but over 100, was bereaved.
After a traumatic event, multiple clinical consequences may appear in children. Among these consequences, the most common is Post-Traumatic Stress Disorder (PTSD). This pathology includes 4 main symptoms: the reviviscences of the event, avoidance behaviors, alterations of cognition and mood and neurovegetative overactivation. In addition, PTSD contributes to the development of many other mental disorders. It is estimated that 75% of adolescents or children having a comorbid disorder with PTSD. In the literature, the main comorbidities identified in pediatric populations are: anxiety disorders, Attention Deficit Hyperactivity Disorder (ADHD) and depression. There is no recommendation as to the therapeutics to be used in psychotraumatism in pediatric population. Epidemiological studies conducted on the consequences of trauma reveal a high variability in the development of psychopathologies. 6 to 20% of exposed children would develop PTSD after a potentially traumatic situation. Several factors can explain the heterogeneity of the results, including the age, the type of trauma experienced, the violence suffered during this trauma. In Nice, to date, more than 2200 children have consulted: 700 children between July 14 and July 28, 2016, 1100 children were seen between August and December, and about 400 since the creation of the Post Traumatic Pediatric Intersectoral Assessment Center (CE2P), in January 2017. The aim of the study is to characterize the psycho-social factors of risk and / or protection interfering in the children's future, following the mass trauma of 14 July 2016 in Nice on a sample of pediatric population exposed in comparison of children controls.
Non-psychotic hallucinations represent a significant symptomatology in child psychiatry (1) and remain clinical question. The results of our previous study "the physalis child" showed a significant correlation between the persistence of non-psychotic acousto-verbal hallucinations (AVH) and the presence of negative emotions, linked to post traumatic stress disorder (PTSD). It seems important to understand the link between trauma and the presence of non-psychotic AVH in children as the literature shows the risk of progression to psychosis when these AVH persist.The interest of the ancllary study of "the physalis child" would be to prospectively observe the presence or not of non-psychotic AVH in the population with PTSD from the "Program 14-7". The question would then be: "Why in two subjects diagnosed with PTSD, one has non-psychotic HAV and the other does not?" The main objective of this ancillary study will be to identify factors of social and emotional cognition linked to the presence of non-psychotic HAV within the cohort of children exposed to the mass trauma of July 14, 2016 in Nice but also to any type of individual trauma.
The impending opening of the trial of the 14 July attack, the conduct and the media coverage associated with the trial are all factors that could be distressing for the children and families exposed to the attack in Nice. Re-exposure to testimonials and certain images can increase the risk of traumatic reactivation with a return of suppressed fears and the symptoms associated. Some factors have been identified as protective: social and family support, cognitive functioning, the presence of residual symptoms or the quality of sleep.
Therefore, an assessment of these factors before and after the opening of the trial would identify children and families with traumatic reactivation, as well as identify protective or risk factors for relapse of traumatic symptoms
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
impacted by the attack of 14 July 2016
characterize the psycho-social factors of risk and / or protection interfering in the children's future with questionnaire following the mass trauma of 14 July 2016 in Nice on a sample of exposed pediatric population
Child and adolescent psychiatry and Epidemiology
psychosocial risk assessment questionnaire, structured diagnostic interview, pedopsychiatric questionnaire
salivary biological collection
Saliva sampling will be done using a specific kit
qualitative analysis of the discourse
two semi-structured interviews, the first with the teenager alone, the second with the lone parents
Parenthood
Parenting Sense of Competence (PSOC) questionnaires completed online.Two visits will be realized: a first in the month preceding the start of the trial and a second in the month following the end of the trial
Cognitive alterations
Episodic memory will be assessed using Grober and Buschke. The evaluation of the cognitive alterations will include two stages: a first in the month preceding the start of the trial and a second in the month following the end of the trial. For child and parents
Impact on schooling
collect of several data about the number of absences of the child, the number of exclusions and hours of detention of the child, as well as the school reports of the child
Sleep disorders and associated somatizations
Evaluation of sleep disorders and associated somatizations by connected watche and sleep questionnaire
control group
characterize the psycho-social factors of risk and / or protection interfering in the children's future with questionnaire of children controls
Child and adolescent psychiatry and Epidemiology
psychosocial risk assessment questionnaire, structured diagnostic interview, pedopsychiatric questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Child and adolescent psychiatry and Epidemiology
psychosocial risk assessment questionnaire, structured diagnostic interview, pedopsychiatric questionnaire
salivary biological collection
Saliva sampling will be done using a specific kit
qualitative analysis of the discourse
two semi-structured interviews, the first with the teenager alone, the second with the lone parents
Parenthood
Parenting Sense of Competence (PSOC) questionnaires completed online.Two visits will be realized: a first in the month preceding the start of the trial and a second in the month following the end of the trial
Cognitive alterations
Episodic memory will be assessed using Grober and Buschke. The evaluation of the cognitive alterations will include two stages: a first in the month preceding the start of the trial and a second in the month following the end of the trial. For child and parents
Impact on schooling
collect of several data about the number of absences of the child, the number of exclusions and hours of detention of the child, as well as the school reports of the child
Sleep disorders and associated somatizations
Evaluation of sleep disorders and associated somatizations by connected watche and sleep questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children and / or young adults under 18 at the time of the Nice attack of 14/07/2016.
* Affiliated to a social security scheme;
* Having a good command of the French language (French);
* Children whose parents have accepted participation in the study (collection of informed consents).
Non inclusion:
* Children and / or young adults with average intellectual disability (Intelligence Quotient IQ less than 50);
* Person deprived of liberty by judicial or administrative decision;
* Person subject to an exclusion period for another search.
Exclusion Criteria
* failure to comply with the instructions defined and exposed at the time of inclusion.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Lenval
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florence ASKENAZY, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpitaux Pédiatriques de Nice CHU-LENVAL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpitaux pédiatriques de Nice CHU-Lenval
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dumas LE, Askenazy F, Fernandez A. Relationships between markers of emotional and social cognition and acoustic-verbal hallucinations in children and adolescents with post-traumatic stress disorder (PTSD). PLoS One. 2025 Sep 23;20(9):e0332910. doi: 10.1371/journal.pone.0332910. eCollection 2025.
Dumas LE, Fernandez A, Auby P, Askenazy F. Relationship between social cognition and emotional markers and acoustic-verbal hallucination in youth with post-traumatic stress disorder: Protocol for a prospective, 2-year, longitudinal case-control study. PLoS One. 2024 Jul 2;19(7):e0306338. doi: 10.1371/journal.pone.0306338. eCollection 2024.
Gindt M, Thummler S, Soubelet A, Guenole F, Battista M, Askenazy F. Methodology of "14-7" Program: A Longitudinal Follow-Up Study of the Pediatric Population and Their Families Exposed to the Terrorist Attack of Nice on July 14th, 2016. Front Psychiatry. 2019 Sep 12;10:629. doi: 10.3389/fpsyt.2019.00629. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-HPNCL-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.